Prevalent Burdensome Mental Disorders Remain Untreated for Years: Manifesto for Early Diagnosis and Treatment

Wittchen HU, Jacobi F, Rehm J, Gustavsson A, Svensson M, Jönsson B, et al. The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol. 2011;21(9):655–79.CrossRefPubMedGoogle Scholar

Kessler RC, Wang PS. The descriptive epidemiology of commonly occurring mental disorders in the United States. Annu Rev Public Health. 2008;29:115–29.CrossRefPubMedGoogle Scholar

Wittchen HU. The burden of mood disorders. Science. 2012;338(6103):15.CrossRefPubMedGoogle Scholar

Andrade LH, Alonso J, Mneimneh Z, Wells JE, Al-Hamzawi A, Borges G, Bromet E, Bruffaerts R, de Girolamo G, de Graaf R, Florescu S, Gureje O, Hinkov HR, Hu C, Huang Y, Hwang I, Jin R, Karam EG, Kovess-Masfety V, Levinson D, Matschinger H, O’Neill S, Posada-Villa J, Sagar R, Sampson NA, Sasu C, Stein DJ, Takeshima T, Viana MC, Xavier M, Kessler RC. Barriers to mental health treatment: results from the WHO World Mental Health surveys. Psychol Med. 2014. doi: 10.1017/S0033291713001943.

McGorry PD. Is early intervention in the major psychiatric disorders justified? Yes. BMJ. 2008;337:a695.CrossRefPubMedGoogle Scholar

Altamura AC, Buoli M, Albano A, Dell’Osso B. Age at onset and latency to treatment (duration of untreated illness) in patients with mood and anxiety disorders: a naturalistic study. Int Clin Psychopharmacol. 2010;25(3):172–9.CrossRefPubMedGoogle Scholar

Dell’Osso B, Glick ID, Baldwin DS, Altamura AC. Can long-term outcomes be improved by shortening the duration of untreated illness in psychiatric disorders? A conceptual framework. Psychopathology. 2013;46(1):14–21.CrossRefPubMedGoogle Scholar

Dell’Osso B, Palazzo M, Arici C, Penzo B, Dobrea C, Oldani L, et al. Development of a short questionnaire for the assessment of the onset and latency to treatment in psychiatric disorders. Int J Neuropsychopharmacol. 2012;15(S1):P-23-049.Google Scholar

Dell’Osso B, Cremaschi L, Palazzo C, Suardi N, Spagnolin G, Camuri G, Benatti B, Oldani, Dobrea C, Arici C, Pace G, Tiseo A, Sembira E, Castellano F, D’Urso N, Clerici M, Primavera D, Carpiniello B, Altamura AC. Factors characterizing access and latency to first pharmacological treatment (duration of untreated illness) in Italian patients with schizophrenia, mood and anxiety spectrum disorders: preliminary results of the First Psychopharmacologic Treatment Access Study (FiPsAS). Int Clin Psychopharmacol. 2014, in press.Google Scholar

Altamura AC, Goodwin GM. How Law 180 in Italy has reshaped psychiatry after 30 years: past attitudes, current trends and unmet needs. Br J Psychiatry. 2010;197(4):261–2.CrossRefPubMedGoogle Scholar

Demyttenaere K, Bruffaerts R, Posada-Villa J, Gasquet I, Kovess V, Lepine JP, et al. Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. JAMA. 2004;291(21):2581–90.CrossRefPubMedGoogle Scholar

ten Have M, de Graaf R, Ormel J, Vilagut G, Kovess V, Alonso J, et al. Are attitudes towards mental health help-seeking associated with service use? Results from the European Study of Epidemiology of Mental Disorders. Soc Psychiatry Psychiatr Epidemiol. 2010;45(2):153–63.CrossRefPubMedCentralPubMedGoogle Scholar

Fife SA, Ketzenberger KE, Olson JN. Attitudes toward psychotropic medications. Psychol Rep. 2012;110(2):475–6.CrossRefPubMedGoogle Scholar

De Las Cuevas C, Sanz EJ. Attitudes toward psychiatric drug treatment: the experience of being treated. Eur J Clin Pharmacol. 2007;63(11):1063–7.CrossRefPubMedGoogle Scholar